Cita APA

Ferrer Font, L. (2017). Tuning response to therapy in preclinical GL261 glioblastoma through CK2 targeting and temozolomide metronomic approaches: Non-invasive assessment with MRI and MRSI-based molecular imaging strategies.

Citación estilo Chicago

Ferrer Font, Laura. Tuning Response to Therapy in Preclinical GL261 Glioblastoma Through CK2 Targeting and Temozolomide Metronomic Approaches: Non-invasive Assessment With MRI and MRSI-based Molecular Imaging Strategies. 2017.

Cita MLA

Ferrer Font, Laura. Tuning Response to Therapy in Preclinical GL261 Glioblastoma Through CK2 Targeting and Temozolomide Metronomic Approaches: Non-invasive Assessment With MRI and MRSI-based Molecular Imaging Strategies. 2017.